POS1382 RITUXIMAB FOR INDUCTION OF REMISSION IN TYPE 1 AUTOIMMUNE PANCREATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Volume: 80, Issue: Suppl 1, Pages: 974.2 - 974
Published: May 19, 2021
Abstract
Background: Type I autoimmune pancreatitis (AIP) is a rare form of pancreatitis that belongs to the IgG4-related disease (IgG4-RD) spectrum (1). Autoimmune pancreatitis responds brilliantly to glucocorticoids, but iatrogenic toxicity associated with prolonged steroid therapy represents a relevant clinical concern in the long-term (2). B cell depletion therapy proved to be effective in inducing IgG4-RD remission, yet most evidence are derived...
Paper Details
Title
POS1382 RITUXIMAB FOR INDUCTION OF REMISSION IN TYPE 1 AUTOIMMUNE PANCREATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Published Date
May 19, 2021
Volume
80
Issue
Suppl 1
Pages
974.2 - 974
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History